São Paulo - Delayed Quote BRL

BeiGene, Ltd. (B1GN34.SA)

Compare
44.00 -0.25 (-0.56%)
At close: September 13 at 11:46 AM GMT-3
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
3,096,535.00
2,458,779.00
1,415,921.00
1,176,283.00
308,874.00
--
Cost of Revenue
465,208.00
379,920.00
286,475.00
164,906.00
70,657.00
--
Gross Profit
2,631,327.00
2,078,859.00
1,129,446.00
1,011,377.00
238,217.00
--
Operating Expense
3,517,599.00
3,286,595.00
2,919,111.00
2,450,112.00
1,895,899.00
--
Operating Income
-886,272.00
-1,207,736.00
-1,789,665.00
-1,438,735.00
-1,657,682.00
--
Net Non Operating Interest Income Expense
72,308.00
74,009.00
52,480.00
-15,757.00
1,998.00
--
Other Income Expense
343,184.00
307,891.00
-223,852.00
15,904.00
37,490.00
--
Pretax Income
-470,780.00
-825,836.00
-1,961,037.00
-1,438,588.00
-1,618,194.00
--
Tax Provision
52,915.00
55,872.00
42,778.00
19,228.00
10,397.00
--
Net Income Common Stockholders
-523,695.00
-881,708.00
-2,003,815.00
-1,457,816.00
-1,624,974.00
--
Diluted NI Available to Com Stockholders
-523,695.00
-881,708.00
-2,003,815.00
-1,457,816.00
-1,624,974.00
--
Basic EPS
-0.38
-0.65
-1.49
-1.17
-1.47
--
Diluted EPS
-0.38
-0.65
-1.49
-1.17
-1.47
--
Basic Average Shares
1,357,586.47
1,357,034.55
1,340,729.57
1,206,210.05
1,085,131.78
--
Diluted Average Shares
1,357,586.47
1,357,034.55
1,340,729.57
1,206,210.05
1,085,131.78
--
Total Operating Income as Reported
-886,272.00
-1,207,736.00
-1,789,665.00
-1,438,735.00
-1,657,682.00
--
Total Expenses
3,982,807.00
3,666,515.00
3,205,586.00
2,615,018.00
1,966,556.00
--
Net Income from Continuing & Discontinued Operation
-523,695.00
-881,708.00
-2,003,815.00
-1,457,816.00
-1,624,974.00
--
Normalized Income
-523,695.00
-881,708.00
-2,003,815.00
-1,457,816.00
-1,624,974.00
--
Interest Income
--
--
--
--
1,998.00
9,131.00
Net Interest Income
72,308.00
74,009.00
52,480.00
-15,757.00
1,998.00
--
EBIT
-886,272.00
-1,207,736.00
-1,789,665.00
-1,438,735.00
-1,657,682.00
--
EBITDA
-790,719.00
-1,120,061.00
-1,723,387.00
-1,392,278.00
-1,625,893.00
--
Reconciled Cost of Revenue
372,780.00
295,745.00
220,948.00
119,199.00
39,714.00
--
Reconciled Depreciation
95,553.00
87,675.00
66,278.00
46,457.00
31,789.00
--
Net Income from Continuing Operation Net Minority Interest
-523,695.00
-881,708.00
-2,003,815.00
-1,457,816.00
-1,624,974.00
--
Normalized EBITDA
-790,719.00
-1,120,061.00
-1,723,387.00
-1,392,278.00
-1,625,893.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
12/31/2019 - 10/20/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade